Literature DB >> 33106926

Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation (4Is)-related cardiovascular diseases: a joint collaboration of the EACVI and the EANM.

Riemer H J A Slart1,2,3, Andor W J M Glaudemans4, Olivier Gheysens5, Mark Lubberink6, Tanja Kero6,7, Marc R Dweck8, Gilbert Habib9,10, Oliver Gaemperli11, Antti Saraste12,13, Alessia Gimelli14, Panagiotis Georgoulias15, Hein J Verberne16, Jan Bucerius17, Christoph Rischpler18, Fabien Hyafil19,20, Paola A Erba4,21,22.   

Abstract

With this document, we provide a standard for PET/(diagnostic) CT imaging procedures in cardiovascular diseases that are inflammatory, infective, infiltrative, or associated with dysfunctional innervation (4Is). This standard should be applied in clinical practice and integrated in clinical (multicenter) trials for optimal procedural standardization. A major focus is put on procedures using [18F]FDG, but 4Is PET radiopharmaceuticals beyond [18F]FDG are also described in this document. Whilst these novel tracers are currently mainly applied in early clinical trials, some multicenter trials are underway and we foresee in the near future their use in clinical care and inclusion in the clinical guidelines. Finally, PET/MR applications in 4Is cardiovascular diseases are also briefly described. Diagnosis and management of 4Is-related cardiovascular diseases are generally complex and often require a multidisciplinary approach by a team of experts. The new standards described herein should be applied when using PET/CT and PET/MR, within a multimodality imaging framework both in clinical practice and in clinical trials for 4Is cardiovascular indications.

Entities:  

Keywords:  4Is; Cardiovascular diseases; PET/CT; Procedural recommendations

Year:  2020        PMID: 33106926     DOI: 10.1007/s00259-020-05066-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  116 in total

1.  Acceptance testing for nuclear medicine instrumentation.

Authors:  Ellinor Busemann Sokole; Anna Płachcínska; Alan Britten
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-03       Impact factor: 9.236

2.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

3.  Recommendations on nuclear and multimodality imaging in IE and CIED infections.

Authors:  Paola Anna Erba; Patrizio Lancellotti; Isidre Vilacosta; Oliver Gaemperli; Francois Rouzet; Marcus Hacker; Alberto Signore; Riemer H J A Slart; Gilbert Habib
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-05-24       Impact factor: 9.236

4.  EANM/SNMMI guideline for 18F-FDG use in inflammation and infection.

Authors:  Francois Jamar; John Buscombe; Arturo Chiti; Paul E Christian; Dominique Delbeke; Kevin J Donohoe; Ora Israel; Josep Martin-Comin; Alberto Signore
Journal:  J Nucl Med       Date:  2013-01-28       Impact factor: 10.057

5.  SNMMI Procedure Standard/EANM Practice Guideline for Amyloid PET Imaging of the Brain 1.0.

Authors:  Satoshi Minoshima; Alexander E Drzezga; Henryk Barthel; Nicolaas Bohnen; Mehdi Djekidel; David H Lewis; Chester A Mathis; Jonathan McConathy; Agneta Nordberg; Osama Sabri; John P Seibyl; Margaret K Stokes; Koen Van Laere
Journal:  J Nucl Med       Date:  2016-08       Impact factor: 10.057

6.  Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography.

Authors:  M Schwaiger; V Kalff; K Rosenspire; M S Haka; E Molina; G D Hutchins; M Deeb; E Wolfe; D M Wieland
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

7.  FDG PET/CT: EANM procedure guidelines for tumour imaging: version 2.0.

Authors:  Ronald Boellaard; Roberto Delgado-Bolton; Wim J G Oyen; Francesco Giammarile; Klaus Tatsch; Wolfgang Eschner; Fred J Verzijlbergen; Sally F Barrington; Lucy C Pike; Wolfgang A Weber; Sigrid Stroobants; Dominique Delbeke; Kevin J Donohoe; Scott Holbrook; Michael M Graham; Giorgio Testanera; Otto S Hoekstra; Josee Zijlstra; Eric Visser; Corneline J Hoekstra; Jan Pruim; Antoon Willemsen; Bertjan Arends; Jörg Kotzerke; Andreas Bockisch; Thomas Beyer; Arturo Chiti; Bernd J Krause
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-12-02       Impact factor: 9.236

Review 8.  EANM/EARL harmonization strategies in PET quantification: from daily practice to multicentre oncological studies.

Authors:  Nicolas Aide; Charline Lasnon; Patrick Veit-Haibach; Terez Sera; Bernhard Sattler; Ronald Boellaard
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-06-16       Impact factor: 9.236

9.  Detection of Atherosclerotic Inflammation by 68Ga-DOTATATE PET Compared to [18F]FDG PET Imaging.

Authors:  Jason M Tarkin; Francis R Joshi; Nicholas R Evans; Mohammed M Chowdhury; Nichola L Figg; Aarti V Shah; Lakshi T Starks; Abel Martin-Garrido; Roido Manavaki; Emma Yu; Rhoda E Kuc; Luigi Grassi; Roman Kreuzhuber; Myrto A Kostadima; Mattia Frontini; Peter J Kirkpatrick; Patrick A Coughlin; Deepa Gopalan; Tim D Fryer; John R Buscombe; Ashley M Groves; Willem H Ouwehand; Martin R Bennett; Elizabeth A Warburton; Anthony P Davenport; James H F Rudd
Journal:  J Am Coll Cardiol       Date:  2017-04-11       Impact factor: 24.094

10.  18F-fluoride positron emission tomography for identification of ruptured and high-risk coronary atherosclerotic plaques: a prospective clinical trial.

Authors:  Nikhil V Joshi; Alex T Vesey; Michelle C Williams; Anoop S V Shah; Patrick A Calvert; Felicity H M Craighead; Su Ern Yeoh; William Wallace; Donald Salter; Alison M Fletcher; Edwin J R van Beek; Andrew D Flapan; Neal G Uren; Miles W H Behan; Nicholas L M Cruden; Nicholas L Mills; Keith A A Fox; James H F Rudd; Marc R Dweck; David E Newby
Journal:  Lancet       Date:  2013-11-11       Impact factor: 79.321

View more
  12 in total

Review 1.  FDG PET/CT in Cardiac Infection: Does It Matter? A Narrative Review.

Authors:  Nesrin Ghanem-Zoubi
Journal:  Infect Dis Ther       Date:  2022-07-30

Review 2.  Cardiovascular positron emission tomography: established and emerging role in cardiovascular diseases.

Authors:  Amit Bansal; Karthikeyan Ananthasubramaniam
Journal:  Heart Fail Rev       Date:  2022-09-21       Impact factor: 4.654

Review 3.  2-deoxy-2[18F]fluoro-D-glucose positron emission tomography-computed tomography in rheumatological diseases.

Authors:  Manil Subesinghe; Shaheel Bhuva; Nikita Arumalla; Andrew Cope; David D'Cruz; Sujith Subesinghe
Journal:  Rheumatology (Oxford)       Date:  2022-05-05       Impact factor: 7.046

4.  Preparing for the next vintage in IE.

Authors:  Paola Anna Erba; Ora Israel
Journal:  J Nucl Cardiol       Date:  2021-07-30       Impact factor: 3.872

5.  Combined simultaneous FDG-PET/MRI with T1 and T2 mapping as an imaging biomarker for the diagnosis and prognosis of suspected cardiac sarcoidosis.

Authors:  Edward Cheung; Sarah Ahmad; Matthew Aitken; Rosanna Chan; Robert M Iwanochko; Meyer Balter; Ur Metser; Patrick Veit-Haibach; Filio Billia; Yasbanoo Moayedi; Heather J Ross; Kate Hanneman
Journal:  Eur J Hybrid Imaging       Date:  2021-12-16

6.  Procedural recommendations of cardiac PET/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a joint collaboration of the EACVI and the EANM: summary.

Authors:  Riemer H J A Slart; Andor W J M Glaudemans; Olivier Gheysens; Mark Lubberink; Tanja Kero; Marc R Dweck; Gilbert Habib; Oliver Gaemperli; Antti Saraste; Alessia Gimelli; Panagiotis Georgoulias; Hein J Verberne; Jan Bucerius; Christoph Rischpler; Fabien Hyafil; Paola A Erba
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2020-12-01       Impact factor: 6.875

Review 7.  A Review on the Value of Imaging in Differentiating between Large Vessel Vasculitis and Atherosclerosis.

Authors:  Pieter H Nienhuis; Gijs D van Praagh; Andor W J M Glaudemans; Elisabeth Brouwer; Riemer H J A Slart
Journal:  J Pers Med       Date:  2021-03-23

Review 8.  Nuclear Imaging in Infective Endocarditis.

Authors:  Nidaa Mikail; Fabien Hyafil
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-22

Review 9.  State of the art of 18F-FDG PET/CT application in inflammation and infection: a guide for image acquisition and interpretation.

Authors:  Massimiliano Casali; Chiara Lauri; Corinna Altini; Francesco Bertagna; Gianluca Cassarino; Angelina Cistaro; Anna Paola Erba; Cristina Ferrari; Ciro Gabriele Mainolfi; Andrea Palucci; Napoleone Prandini; Domenico Albano; Luca Burroni; Alberto Cuocolo; Laura Evangelista; Elena Lazzeri; Natale Quartuccio; Brunella Rossi; Giuseppe Rubini; Martina Sollini; Annibale Versari; Alberto Signore; Sergio Baldari; Francesco Bartoli; Mirco Bartolomei; Adriana D'Antonio; Francesco Dondi; Patrizia Gandolfo; Alessia Giordano; Riccardo Laudicella; Michela Massollo; Alberto Nieri; Arnoldo Piccardo; Laura Vendramin; Francesco Muratore; Valentina Lavelli
Journal:  Clin Transl Imaging       Date:  2021-07-10

Review 10.  18F-FDG PET/CT in Infective Endocarditis: Indications and Approaches for Standardization.

Authors:  D Ten Hove; R H J A Slart; B Sinha; A W J M Glaudemans; R P J Budde
Journal:  Curr Cardiol Rep       Date:  2021-08-07       Impact factor: 2.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.